Gastroesophageal reflux disease the long and the short of therapeutic options

Postgraduate Medicine

Volumn 100, Issue 5, 1996, Pages 76-89

  Brady, William M ^a,b   Ogorek, Carrie P ^a,b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 7Th Floor ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; ANTACID AGENT; CIMETIDINE; CISAPRIDE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METOCLOPRAMIDE; NIZATIDINE; NON PRESCRIPTION DRUG; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; SUCRALFATE;

BEHAVIOR MODIFICATION; CARCINOID; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; LONG TERM CARE; NEUROTOXICITY; RELAPSE; STOMACH FUNDOPLICATION;

ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL AGENTS; HISTAMINE H2 ANTAGONISTS; HUMANS;

EID: 0029993866     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1996.11.110     Document Type: Article

References (21)

1. Heartburn across America: a Gallup Organization survey. Princeton, NJ: Gallup Organization, 1988
2. Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976;21(11): 953-6
3. Ogorek CP, Fisher RS. Detection and treatment of gastroesophageal reflux disease. Gastroenterol Clin North Am 1989;18(2):293-313
4. Castell DO, Dalton CB, Becker D, et al. AJginic acid decreases postprandial upright gastroesophageal reflux: comparison with equal-strength antacid. Dig Dis Sei 1992;37(4):589-93
5. Johnson DA. Medical therapy for gastroesophageal reflux disease. Am J Med 1992;92(Suppl 5A):88-97S
6. Castell DO. Rationale for high-dose H2-receptor blockade in the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol T her 1991;5(Suppl l):59-67
7. Russell J, Orr WC, Wilson T, et al. Effects of ranitidine, given t.d.s., on intragastric and oesophageal pH in patients with gastrooesophageal reflux. Aliment Pharmacol Ther 1991;5(6):621-30
8. Hixson LJ, Kelley CL, Jones WN, et al. Current trends in the pharmacotherapy for gastroesophageal reflux disease. Arch Intern Med 1992; 152(4)717-23
9. McCaUum RW, Fink SM, Winnan GR, et al. Metoclopramide in gastroesophageal reflux disease: rationale for its use and results of a doubleblind trial. Am J Gastroenterol 1984;79(3):165-72
10. Wienbeck M, Li Q. Cisapride in gastro-oesophageal reflux disease: etfeets on oesophageal motility and inrra-oesophageal pH. Scand J Gastroenterol 1989;(Suppl 165):13-8
11. Richter JE. Efficacy of cisapride on symptoms and healing of gastrooesophageal reflux disease: a review. Scand J Gastroenterol 1989;(Suppl 165): 19-28
12. Galmiche JP, Fraitag B, Filoche B, et al. Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis. Dig Dis Sei 1990;35(5):649-55
13. Inauen W, Emde C, Weber B, et al. Effects of ranitidine and cisapride on acid reflux and oesophageal motihty in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study. Gut 1993;34(8):1025-31
14. Meuwissen SG, Klinkenberg-KnoI EC. Management of gasttooesophageat reflux disease: are there alternatives to omeprazole? Digestion 1989;44(Suppl l):54-62
15. Williams RM, Orlando RC, Bozymski EM, et al. Multicenter trial of sucralfate suspension for the treatment of reflux esophagitis. Am J Med 1987;83(Suppl3B):61-6
16. Fennerty MB, Castell D, Fendrick AM, et al. The diagnosis and treatment of gastroesophageal reflux disease in a managed care environment: suggested disease management guidelines. Arch Intern Med 1996; 156(5):477-84
17. Vigneri S, Termini R, Leandro G, et al. A comparison uf five maintenance therapies tor reflux esophagitis. N Engl J Med 1995:333(17): 1106-10
18. Tytgat GN, Anker Hansen OJ, Carling L, et al. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug. Scand J Gastroenterol 1992;27(3): 175-83
19. Robinson M, Lanza F, Avner D, et al. Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole- a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1996;124(10):859-67
20. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, et al. Atrophie gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996;334(16): 1018-22
21. Dehn TC. Surgery for uncomplicated gastrooesophageal reflux. Gtit 1992;33(3):293-4